Investigation of Analgesic and Anti-inflammatory Effects of Beta-adrenergic Antagonist Propranolol

Completed Not Applicable NCT01094574

Study Description

Previous studies have shown that the beta-adrenergic system plays a role in processing pain and the expression of hyperalgesia. Recent studies have investigated the analgesic effects, and potential anti-hyperalgesic effects (using a model of opioid induced (OIH) hyperalgesia) of propranolol, a beta adrenergic antagonist. We plan to further investigate the analgesic effects, and the potential anti inflammatory effects, of propranolol and compare those effects to alfentanil, an opioid of known effect, and placebo

Study Details

Registry ID:
NCT01094574
Conditions:
Pain Measurement
Phase:
Not Applicable
Target Enrollment:
10 participants
Start Date:
Age Range:
0–999 years
Healthy Volunteers:
No

Study Locations (1 site)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →